EA201691071A1 - Фенилтриазолопиридиновые соединения - Google Patents
Фенилтриазолопиридиновые соединенияInfo
- Publication number
- EA201691071A1 EA201691071A1 EA201691071A EA201691071A EA201691071A1 EA 201691071 A1 EA201691071 A1 EA 201691071A1 EA 201691071 A EA201691071 A EA 201691071A EA 201691071 A EA201691071 A EA 201691071A EA 201691071 A1 EA201691071 A1 EA 201691071A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- pheniltriazolopiridine
- compounds
- och
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Согласно настоящему изобретению предложено соединение формулы Iгде Rвыбран из группы, состоящей из H, CH, CN, -CHCN, -C(CH)CN, F, Cl и Br; Rвыбран из группы, состоящей из H, -O(C-Салкилен)R, -CHCN, CN, -OCH, CF, -C(CH)CN, -C(CH), -S(O)CH, -S(O)NHи -OCF; Rвыбран из группы, состоящей из H, CHи -OCH; и Rвыбран из группы, состоящей из H,-C(CH)CN, -OCH, -S(O)CH, CN и -C(CH)OH; или его фармацевтически приемлемая соль, способы лечения диабета второго типа с использованием указанного соединения и способ получения указанного соединения.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461925802P | 2014-01-10 | 2014-01-10 | |
| PCT/US2015/010291 WO2015105786A1 (en) | 2014-01-10 | 2015-01-06 | Phenyl-triazolo-pyridine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201691071A1 true EA201691071A1 (ru) | 2016-11-30 |
Family
ID=52440835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201691071A EA201691071A1 (ru) | 2014-01-10 | 2015-01-06 | Фенилтриазолопиридиновые соединения |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9617263B2 (ru) |
| EP (1) | EP3092241B1 (ru) |
| JP (1) | JP6211200B2 (ru) |
| KR (1) | KR20160095117A (ru) |
| CN (1) | CN105873929B (ru) |
| AU (1) | AU2015204923A1 (ru) |
| BR (1) | BR112016013874A2 (ru) |
| CA (1) | CA2931822A1 (ru) |
| EA (1) | EA201691071A1 (ru) |
| ES (1) | ES2653425T3 (ru) |
| MX (1) | MX2016008910A (ru) |
| WO (1) | WO2015105786A1 (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9809592B2 (en) | 2014-01-10 | 2017-11-07 | Eli Lilly And Company | Isopropyl triazolo pyridine compounds |
| PT3737470T (pt) | 2018-01-08 | 2023-03-02 | Celon Pharma Sa | Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40 |
| PE20210640A1 (es) | 2018-02-13 | 2021-03-23 | Gilead Sciences Inc | Inhibidores pd-1/pd-l1 |
| TWI712412B (zh) | 2018-04-19 | 2020-12-11 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
| ES2962674T3 (es) | 2018-07-13 | 2024-03-20 | Gilead Sciences Inc | Inhibidores PD-1/PD-L1 |
| CN112955435B (zh) | 2018-10-24 | 2024-09-06 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
| US20220281866A1 (en) * | 2019-07-19 | 2022-09-08 | Janssen Pharmaceutica Nv | 5,8-disubstituted-[1,2,4]triazolo[1,5-a]pyridinyl and 5,8-disubstituted-imidazo[1,2-a]pyridine derivatives useful as inhibitors of enteropeptidase |
| AU2020363377A1 (en) | 2019-10-07 | 2022-04-21 | Kallyope, Inc. | GPR119 agonists |
| CA3178994A1 (en) | 2020-05-19 | 2021-11-25 | Iyassu Sebhat | Ampk activators |
| AU2021297323A1 (en) | 2020-06-26 | 2023-02-16 | Kallyope, Inc. | AMPK activators |
| CN115317484B (zh) * | 2022-08-26 | 2023-07-18 | 北京箭牧科技有限公司 | Ly2922470在制备预防或治疗脑血管疾病或组织缺血再灌注损伤药物中的应用 |
| CN115671105B (zh) * | 2022-11-22 | 2023-10-27 | 北京箭牧科技有限公司 | Ly2922470在制备预防或治疗肾脏疾病药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1559422B1 (en) | 2002-11-08 | 2014-04-30 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| EP1737809B1 (en) * | 2004-02-27 | 2013-09-18 | Amgen, Inc | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| US9271969B2 (en) | 2012-02-07 | 2016-03-01 | Kainos Medicine, Inc. | Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
| TW201609722A (zh) * | 2013-12-13 | 2016-03-16 | 美國禮來大藥廠 | 新穎三唑并吡啶化合物 |
| US9809592B2 (en) | 2014-01-10 | 2017-11-07 | Eli Lilly And Company | Isopropyl triazolo pyridine compounds |
-
2015
- 2015-01-06 CN CN201580004127.3A patent/CN105873929B/zh active Active
- 2015-01-06 EA EA201691071A patent/EA201691071A1/ru unknown
- 2015-01-06 ES ES15702019.9T patent/ES2653425T3/es active Active
- 2015-01-06 BR BR112016013874A patent/BR112016013874A2/pt not_active IP Right Cessation
- 2015-01-06 WO PCT/US2015/010291 patent/WO2015105786A1/en active Application Filing
- 2015-01-06 EP EP15702019.9A patent/EP3092241B1/en active Active
- 2015-01-06 JP JP2016544801A patent/JP6211200B2/ja not_active Expired - Fee Related
- 2015-01-06 AU AU2015204923A patent/AU2015204923A1/en not_active Abandoned
- 2015-01-06 US US15/106,998 patent/US9617263B2/en active Active
- 2015-01-06 KR KR1020167018137A patent/KR20160095117A/ko active Search and Examination
- 2015-01-06 CA CA2931822A patent/CA2931822A1/en not_active Abandoned
- 2015-01-06 MX MX2016008910A patent/MX2016008910A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016008910A (es) | 2016-10-04 |
| US9617263B2 (en) | 2017-04-11 |
| CN105873929A (zh) | 2016-08-17 |
| WO2015105786A1 (en) | 2015-07-16 |
| ES2653425T3 (es) | 2018-02-07 |
| JP2017503800A (ja) | 2017-02-02 |
| CN105873929B (zh) | 2018-04-06 |
| KR20160095117A (ko) | 2016-08-10 |
| CA2931822A1 (en) | 2015-07-16 |
| JP6211200B2 (ja) | 2017-10-11 |
| EP3092241B1 (en) | 2017-10-04 |
| AU2015204923A1 (en) | 2016-06-09 |
| BR112016013874A2 (pt) | 2017-08-08 |
| EP3092241A1 (en) | 2016-11-16 |
| US20170029420A1 (en) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201691071A1 (ru) | Фенилтриазолопиридиновые соединения | |
| EA201690153A1 (ru) | Замещенные бензофуранильные и бензоксазолильные соединения и их применения | |
| EA201691150A1 (ru) | Соединения изопропилтриазолопиридина | |
| EA201690879A1 (ru) | Новое триазолопиридиновое соединение | |
| EA201791002A1 (ru) | Новые соединения, модулирующие fxr (nr1h4) | |
| EA201892480A1 (ru) | Соединения, модулирующие fxr (nr1h4) | |
| EA201892482A1 (ru) | Соединения, модулирующие fxr (nr1h4) | |
| EA201991198A1 (ru) | АМИНОТИАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-Kit | |
| EA201890522A1 (ru) | Способ получения противогрибковых соединений | |
| EA201591382A1 (ru) | Ингибиторы гистондеметилаз | |
| EA201791070A1 (ru) | Способы получения ингибиторов ask1 | |
| EA201692418A1 (ru) | Замещенные индазольные соединения в качестве irak4 ингибиторов | |
| TN2017000204A1 (en) | Triazolopyrimidine compounds and uses thereof | |
| EA201690094A1 (ru) | Ингибиторы syk | |
| MX2020001757A (es) | Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades. | |
| EA201990833A1 (ru) | Соединение пиридина | |
| EA201592126A1 (ru) | 6-мостиковые гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
| EA201690268A1 (ru) | Замещенные производные хиназолин-4-она | |
| EA201791656A1 (ru) | Соединения 4-метилсульфонилзамещенной пиперидинмочевины для лечения дилатационной кардиомиопатии (dcm) | |
| EA201591491A1 (ru) | Соединения тетрагидропирролотиазина | |
| EA201790328A1 (ru) | Диоксолановые аналоги уридина для лечения рака | |
| EA201490269A1 (ru) | Новое производное 1,2,3,4-тетрагидрохинолина, подходящее для лечения диабета | |
| EA201991580A1 (ru) | Пиримидиновое соединение и его фармацевтическое применение | |
| AR105668A1 (es) | 2-amino-3-fluoro-3-(fluorometil)-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
| EA201690911A1 (ru) | Соединения диметилбензойной кислоты |